…
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Trulieve Cannabis Corp is a vertically integrated multi-state cannabis operator that cultivates, processes and sells cannabis products through a network of dispensaries, with a strong presence in Florida. Long-term growth could come from adding retail locations, expanding product lines and consolidating regional markets, and investors may view scale and distribution as advantages.
Material risks include federal and state regulatory uncertainty, concentration in core state markets (especially Florida), intense competition and pricing pressure, integration risks from acquisitions, and constrained access to banking and capital.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 91.47M | 42.71M | -284.54M | -43.30M | 163.51M |
| Minority interest | 5.87M | 5.47M | 6.34M | 6.70M | 0.59M |
| Net income | -116.38M | -155.10M | -526.80M | -246.10M | 18.03M |
| Selling general administrative | 445.21M | 510.45M | 386.16M | 454.60M | 315.72M |
| Gross profit | 711.17M | 715.75M | 588.63M | 682.00M | 566.13M |
| Reconciled depreciation | 173.40M | 166.37M | 170.66M | 119.40M | 78.22M |
| Ebit | - | - | - | 133.76M | 261.95M |
| Ebitda | - | - | - | 155.90M | 276.51M |
| Operating income | 148.32M | 92.49M | 92.64M | 108.00M | 202.32M |
| Interest expense | 63.45M | 62.19M | 81.57M | 79.80M | 34.79M |
| Tax provision | 208.11M | 197.59M | 151.36M | 161.80M | 146.06M |
| Interest income | 14.52M | 14.68M | 6.16M | - | - |
| Net interest income | -48.93M | -47.52M | -75.41M | -79.80M | -34.79M |
| Income tax expense | - | - | - | 161.82M | 146.70M |
| Total revenue | 1181.18M | 1186.49M | 1129.19M | 1239.80M | 938.38M |
| Total operating expenses | 1032.86M | 1094.00M | 1036.55M | 1131.80M | 736.07M |
| Cost of revenue | 470.01M | 470.75M | 540.57M | 557.80M | 372.25M |
| Total other income expense net | -7.92M | -2.26M | -301.77M | -71.50M | -4.02M |
| Discontinued operations | - | - | - | -47.56M | -1.94M |
| Net income from continuing ops | -116.64M | -154.88M | -435.89M | -205.10M | 17.45M |
| Net income applicable to common shares | - | - | - | -246.06M | 18.03M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2696.10M | 2870.27M | 2729.05M | 3399.00M | 3410.87M |
| Intangible assets | 798.37M | 859.48M | 917.19M | 1012.60M | 1117.98M |
| Other current assets | 25.50M | 26.21M | 23.73M | 49.86M | 27.54M |
| Total liab | 1553.09M | 1621.24M | 1320.44M | 1471.30M | 1263.50M |
| Total stockholder equity | 1143.01M | 1249.03M | 1408.61M | 1931.20M | 2145.82M |
| Other current liab | 4.46M | 9.44M | 7.42M | 100.26M | 55.73M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -912.12M | -795.74M | -640.64M | -113.84M | 137.72M |
| Other liab | - | - | - | 265.14M | 277.17M |
| Good will | 483.90M | 483.90M | 483.90M | 791.50M | 765.36M |
| Other assets | - | - | - | 27.40M | 81.95M |
| Cash | 255.53M | 238.80M | 201.37M | 212.30M | 230.65M |
| Total current liabilities | 126.94M | 138.49M | 114.85M | 209.70M | 169.45M |
| Net debt | - | 241.38M | 281.46M | 436.10M | 248.79M |
| Short long term debt | 4.08M | 3.41M | 3.76M | 12.50M | 10.05M |
| Property plant equipment | - | - | - | 974.56M | 957.90M |
| Total current assets | 562.72M | 604.56M | 477.35M | 592.95M | 524.93M |
| Net tangible assets | - | - | - | 127.02M | 299.22M |
| Short term investments | 0.00M | 60.39M | 0.00M | - | - |
| Net receivables | 10.50M | 8.29M | 6.70M | 10.84M | 19.94M |
| Long term debt | 227.58M | 476.78M | 479.07M | 635.90M | 469.38M |
| Inventory | 242.30M | 231.37M | 213.12M | 297.81M | 209.94M |
| Accounts payable | 26.78M | 20.23M | 28.25M | 16.41M | 14.34M |
| Non currrent assets other | 11.93M | 21.82M | 12.39M | 15.40M | 18.31M |
| Non current assets total | 2133.38M | 2265.71M | 2251.71M | 2806.00M | 2886.45M |
| Capital lease obligations | 331.97M | 344.27M | 309.74M | 380.90M | 379.59M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 60.00M | -60.00M | -37.47M | -215.06M | -215.18M |
| Change to liabilities | - | - | - | 1.55M | -14.30M |
| Total cashflows from investing activities | - | - | - | -215.06M | -215.18M |
| Net borrowings | -393.35M | -15.74M | -174.29M | 159.90M | 64.64M |
| Total cash from financing activities | -270.50M | -33.44M | -175.59M | 177.80M | 289.23M |
| Change to operating activities | - | - | - | 10.60M | -33.11M |
| Net income | -116.38M | -155.10M | -526.80M | -246.06M | 18.03M |
| Change in cash | 15.82M | 31.43M | -11.21M | -14.22M | 86.39M |
| Begin period cash flow | 239.71M | 207.98M | 213.79M | 233.10M | 146.71M |
| End period cash flow | 255.53M | 239.71M | 207.98M | 218.87M | 233.66M |
| Total cash from operating activities | 272.82M | 271.48M | 201.84M | 23.10M | 12.90M |
| Issuance of capital stock | 140.00M | 0.00M | 0.00M | 0.00M | 217.90M |
| Depreciation | 173.40M | 177.89M | 180.99M | 185.57M | 78.22M |
| Other cashflows from investing activities | - | - | - | 1.47M | -3.84M |
| Dividends paid | - | - | 0.05M | - | - |
| Change to inventory | -10.93M | -18.73M | 83.30M | -83.43M | -19.57M |
| Change to account receivables | -3.72M | 0.74M | -1.71M | -4.21M | -4.90M |
| Other cashflows from financing activities | - | - | - | -0.88M | -0.25M |
| Change to netincome | - | - | - | 139.32M | 1.51M |
| Capital expenditures | 60.51M | 154.66M | 55.49M | 182.73M | 306.12M |
| Change in working capital | 188.17M | 234.88M | 174.11M | -55.73M | -84.86M |
| Stock based compensation | 20.47M | 20.20M | 10.57M | 18.12M | 9.25M |
| Other non cash items | 25.04M | 8.99M | 75.66M | 78.51M | 13.94M |
| Free cash flow | 212.31M | 116.82M | 146.35M | -161.49M | -283.98M |
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DOGEF Orsted A/S |
- -% |
20.13 | 28.82 | 0.66 | 6.50 | 0.07 | 3.88 | 15.58 |
| TBB AT&T Inc. 5.35% GLB NTS 66 |
0.13 0.74% |
17.73 | 4.60 | - | - | - | - | - |
| CCZ Comcast Holdings Corp |
- -% |
62.32 | 55.07 | - | - | - | - | - |
| STMZF Scottish Mortgage Investment Trust PLC |
-1.09 5.69% |
18.00 | - | - | 2.56 | - | - | - |
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
3494 Martin Hurst Road, Tallahassee, FL, United States, 32312
850 298 8866
5000
| Name | Title | Year Born |
|---|---|---|
| Ms. Kimberly Rivers | Founder, Chairman & CEO | 1978 |
| Mr. Alex D'Amico CPA | Chief Financial Officer | 1975 |
| Mr. Eric Raymond Powers III, J.D. | Chief Legal Officer & Corp. Sec. | 1969 |
| Mr. Steven Mathew White | Pres | 1974 |
| Ms. Rebecca L. Young | VP & Chief Accounting Officer | 1981 |
| Mr. Nilyum Jhala | Chief Technology Officer | NA |
| Mr. Jason Barry Pernell | Chief Information Officer | 1978 |
| Ms. Christine Hersey | Director of Investor Relations | NA |
| Mr. Robert Kremer | Exec. Director of Corp. Communications | NA |
| Ms. Victoria Walker | Director of Marketing & Community Relations | 1985 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.